Literature DB >> 189099

Infectious mononucleosis in children. Evaluation of Epstein-Barr virus-specific serological data.

C M Ginsburg, W Henle, G Henle, C A Horwitz.   

Abstract

Epstein-Barr virus (EBV)-specific antibody responses were determined in 43 consecutive pediatric patients who had signs and symptoms of inectious mononucleosis (IM) and positive diagnostic tests for mononucleosis (Monspot). Thirty patients gave clear-cut serologic evidence of primary EBV infections; of the remaining 13 patients, seven had no antibodies to EBV in the acute- or convalescent-phase sera and six showed serologic patterns of past EBV infections. Further testing proved that the initial Monospot results were either false-positive or were incorrectly interpreted in all 13 patients with unidentifiable illnesses but in only two of the patients with current EBV infections. The data confirm the occurrence of classical IM in children and show that the disease and the EBV-specific antibody responses can be virtually indistinguishable from adult cases.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 189099     DOI: 10.1001/jama.237.8.781

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  9 in total

1.  Application of virus-specific immunoglobulin M (IgM), IgG, and IgA antibody detection with a polyantigenic enzyme-linked immunosorbent assay for diagnosis of Epstein-Barr virus infections in childhood.

Authors:  L Schaade; M Kleines; M Häusler
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

2.  Patterns of Interindividual Variability in the Antibody Repertoire Targeting Proteins Across the Epstein-Barr Virus Proteome.

Authors:  Zhiwei Liu; Anna E Coghill; Ruth M Pfeiffer; Carla Proietti; Wan-Lun Hsu; Yin-Chu Chien; Lea Lekieffre; Lutz Krause; Kelly J Yu; Pei-Jen Lou; Cheng-Ping Wang; Jason Mulvenna; Jaap M Middeldorp; Jeff Bethony; Chien-Jen Chen; Denise L Doolan; Allan Hildesheim
Journal:  J Infect Dis       Date:  2018-05-25       Impact factor: 5.226

Review 3.  Progress and problems in understanding and managing primary Epstein-Barr virus infections.

Authors:  Oludare A Odumade; Kristin A Hogquist; Henry H Balfour
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

4.  Impaired Epstein-Barr Virus-Specific Neutralizing Antibody Response during Acute Infectious Mononucleosis Is Coincident with Global B-Cell Dysfunction.

Authors:  Archana Panikkar; Corey Smith; Andrew Hislop; Nick Tellam; Vijayendra Dasari; Kristin A Hogquist; Michelle Wykes; Denis J Moss; Alan Rickinson; Henry H Balfour; Rajiv Khanna
Journal:  J Virol       Date:  2015-06-24       Impact factor: 5.103

5.  Detection of antibodies to Epstein-Barr virus capsid antigen by immune adherence hemagglutination.

Authors:  E T Lennette; E Ward; G Henle; W Henle
Journal:  J Clin Microbiol       Date:  1982-01       Impact factor: 5.948

Review 6.  Clinical consequences of Epstein-Barr virus infection and possible control by an anti-viral vaccine.

Authors:  M A Epstein; A J Morgan
Journal:  Clin Exp Immunol       Date:  1983-08       Impact factor: 4.330

7.  Primary Epstein-Barr virus infection in early childhood.

Authors:  S Krabbe; J Hesse; P Uldall
Journal:  Arch Dis Child       Date:  1981-01       Impact factor: 3.791

8.  A prospective study on infectious mononucleosis in childhood--symptoms, serology, Epstein-Barr-Virus specific leukocyte migration inhibition.

Authors:  L Timár; J Budai; M Koller
Journal:  Infection       Date:  1982       Impact factor: 3.553

Review 9.  Diagnosis of viral disease and the advent of antiviral drugs.

Authors:  E C Herrmann; J A Herrmann
Journal:  Pharmacol Ther       Date:  1979       Impact factor: 12.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.